11 Ken Griffin Verve Therapeutics Trades
Ken Griffin's position in Verve Therapeutics is currently worth $3 Million. That's 0.00% of their equity portfolio (1895th largest holding). The first Verve Therapeutics trade was made in Q2 2021. Since then Ken Griffin bought shares five more times and sold shares on five occasions. The investor's estimated purchase price is $12.7 Million, resulting in a loss of 76%.
Avg closing price
Price range
Increased shares by 89.6% (+213 Thousand shares)
Q4 2023
Avg closing price
$12.40
Price range
$8.84
-
$18.70
Sold 65.9% shares (-459 Thousand shares)
Q3 2023
Avg closing price
$16.10
Price range
$11.42
-
$20.82
Increased shares by 63.8% (+271 Thousand shares)
Q2 2023
Avg closing price
$16.65
Price range
$13.34
-
$19.90
Increased shares by 1053.5% (+388 Thousand shares)
Q1 2023
Avg closing price
$19.58
Price range
$14.30
-
$24.01
Sold 48.0% shares (-34 Thousand shares)
Q4 2022
Avg closing price
$26.50
Price range
$17.85
-
$40.70
Sold 93.5% shares (-1.01 Million shares)
Q3 2022
Avg closing price
$31.92
Price range
$15.63
-
$41.49
Increased shares by 10.3% (+101 Thousand shares)
Q2 2022
Avg closing price
$15.49
Price range
$11.14
-
$23.17
Increased shares by 79.2% (+433 Thousand shares)
Q1 2022
Avg closing price
$28.58
Price range
$20.92
-
$39.36
Sold 17.9% shares (-119 Thousand shares)
Q4 2021
Avg closing price
$42.01
Price range
$31.94
-
$54.82
Sold 19.7% shares (-163 Thousand shares)
Q3 2021
Avg closing price
$58.83
Price range
$46.00
-
$73.99
New holding (+830 Thousand shares)
Q2 2021
Avg closing price
$41.51
Price range
$31.92
-
$60.25
